Granules India gets ANDA approval for Pantoprazole Sodium DR tablets
Pantoprazole Sodium delayed-release tablets are indicated for short-term treatment of erosive esophagitis associated with GERD
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Sterling Accuris acquires Vaibhav Analytical Services, expands into pharma and analytical testing
With this acquisition, Sterling Accuris has expanded its range of services offered to fields such as pharma analytical testing
Sanofi’s $140 mn investment in Aqemia will accelerate drug discovery through AI: GlobalData
The collaboration is poised to help reshape the landscape of drug development and improve the way new therapeutic compounds are…
Coya, Dr Reddy’s sign pact to develop and market COYA 302 for treatment of ALS
Coya retains the right to commercialise COYA 302 for patients with amyotrophic lateral sclerosis (ALS) in Japan, Mexico, and each…
Future-proofing the pharma cold chain
As India's pharma sector undergoes a transformative shift, an agile and scalable cold chain characterised by innovative…
Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US
Leuprolide acetate for depot suspension is a GnRH agonist used for the treatment of advanced prostatic cancer, endometriosis, and…
Madrigal’s efforts for resmetirom will set tone for future launches of NASH therapies: GlobalData
In December 2022, the company successfully concluded raising a total of $309 million following positive topline data from the…
Merck announces Remarkable Merck Young Scientists Awards 2023
Held at Bangalore, the annual awards recognise the work of young scientists who are driving positive change in the lives of…
Indoco Remedies gets tentative USFDA approval for Canagliflozin Tablets
Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus
Zydus gets final USFDA nod for Methylene Blue Injection
Methylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired…
Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharma market in GCC region, Philippines happens to be the second largest market in South East…
Sentynl completes asset transfer of CUTX-101 Copper Histidinate product candidate for treatment of…
A rolling submission of the CUTX-101 New Drug Application (NDA) to the FDA is ongoing, with expected completion in 2024
Lupin gets US FDA approval for Varenicline Tablets
They are indicated for use as an aid to smoking cessation treatment
Vibcare Healthcare opens pharma manufacturing facility in Panchkula, Haryana
Built with an investment of Rs 40 crores, the facility spans over five acres
Akums’ acquires new formulation facility in Baddi
It is slated to become operational in the year 2024
Non-stimulants face uphill battle to penetrate ADHD market despite lower abuse potential: GlobalData
A better alternative strategy to penetrate the saturated ADHD market would be to target key unmet needs in ADHD treatment such as…
AbbVie’s $10.1 bn Immunogen deal fortifies oncology portfolio, signals big pharma’s ADC…
Earlier this year, Pfizer acquired ADC giant Seagen for $43 billion in one of the largest M&A deals in industry history
Syngene concludes acquisition of biologics facility from Stelis Biopharma
The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs 617 crores adjusted…
Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the US
Turqoz Tablets USP 0.3 mg/0.03 mg is a contraceptive drug indicated to prevent pregnancy
We are committed to delivering excellence across the pharma supply chain
Rajesh Vedak, MD, Körber India speaks about his company's innovative solutions, strategies to maintain its technological…